SCIACOVELLI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 4.709
EU - Europa 1.792
AS - Asia 1.335
SA - Sud America 374
AF - Africa 351
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 14
Totale 8.605
Nazione #
US - Stati Uniti d'America 4.535
IT - Italia 864
SG - Singapore 405
CN - Cina 311
BR - Brasile 279
HK - Hong Kong 221
PL - Polonia 157
DE - Germania 89
FI - Finlandia 88
SE - Svezia 88
RU - Federazione Russa 74
VN - Vietnam 68
NL - Olanda 59
GB - Regno Unito 53
FR - Francia 51
CA - Canada 27
UA - Ucraina 22
IN - India 20
ES - Italia 19
ID - Indonesia 19
EC - Ecuador 18
JP - Giappone 18
MX - Messico 17
ZA - Sudafrica 17
AR - Argentina 16
IE - Irlanda 16
CI - Costa d'Avorio 15
ET - Etiopia 15
MU - Mauritius 14
PT - Portogallo 14
TN - Tunisia 14
GR - Grecia 13
LA - Repubblica Popolare Democratica del Laos 13
TZ - Tanzania 13
AT - Austria 12
BF - Burkina Faso 12
IQ - Iraq 12
LC - Santa Lucia 12
LU - Lussemburgo 12
MA - Marocco 12
NI - Nicaragua 12
PE - Perù 12
RO - Romania 12
TR - Turchia 12
YE - Yemen 12
AL - Albania 11
AO - Angola 11
DZ - Algeria 11
GT - Guatemala 11
NP - Nepal 11
TJ - Tagikistan 11
UZ - Uzbekistan 11
ZW - Zimbabwe 11
AZ - Azerbaigian 10
BE - Belgio 10
BJ - Benin 10
BY - Bielorussia 10
CR - Costa Rica 10
GN - Guinea 10
JO - Giordania 10
KR - Corea 10
MN - Mongolia 10
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
AM - Armenia 9
BW - Botswana 9
CG - Congo 9
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
HU - Ungheria 9
IS - Islanda 9
KE - Kenya 9
LB - Libano 9
MR - Mauritania 9
PA - Panama 9
PS - Palestinian Territory 9
TH - Thailandia 9
VE - Venezuela 9
BB - Barbados 8
CM - Camerun 8
CY - Cipro 8
GA - Gabon 8
ME - Montenegro 8
MG - Madagascar 8
ML - Mali 8
MZ - Mozambico 8
NO - Norvegia 8
SA - Arabia Saudita 8
SI - Slovenia 8
SK - Slovacchia (Repubblica Slovacca) 8
SN - Senegal 8
TL - Timor Orientale 8
TW - Taiwan 8
UY - Uruguay 8
AU - Australia 7
BA - Bosnia-Erzegovina 7
BG - Bulgaria 7
BZ - Belize 7
CU - Cuba 7
CW - ???statistics.table.value.countryCode.CW??? 7
Totale 8.287
Città #
Fairfield 796
Woodbridge 484
Ashburn 374
Houston 340
Ann Arbor 292
Cambridge 291
Chandler 270
Seattle 267
Singapore 257
Wilmington 248
Hong Kong 213
Bytom 141
Boardman 96
Princeton 92
Santa Clara 89
San Diego 80
Beijing 78
Milan 72
Medford 63
Rome 48
Helsinki 47
Padova 45
Nanjing 43
Des Moines 42
Roxbury 41
Jacksonville 40
Los Angeles 26
São Paulo 21
Bologna 20
Jinan 20
Florence 18
Munich 18
Hebei 17
Ho Chi Minh City 17
London 15
New York 15
Dong Ket 14
Nanchang 14
Naples 14
Shenyang 14
Abidjan 13
Buffalo 13
Trento 13
Vientiane 13
Castries 12
Dublin 12
Venezia 12
Dar es Salaam 11
Genoa 11
Managua 11
Amman 10
Baku 10
Conakry 10
Dushanbe 10
Hanoi 10
Harare 10
Berlin 9
Brasília 9
Dallas 9
Jiaxing 9
Luxembourg 9
Montepulciano 9
Nairobi 9
Ouagadougou 9
Rio de Janeiro 9
San José 9
Tashkent 9
Ulan Bator 9
Chicago 8
Cotonou 8
Dakar 8
Guatemala City 8
Hefei 8
Luanda 8
Montevideo 8
Montreal 8
Panama City 8
Antananarivo 7
Atlanta 7
Bamako 7
Bridgetown 7
Castelnuovo Rangone 7
Dili 7
Guangzhou 7
Lisbon 7
Ljubljana 7
Maputo 7
Nouakchott 7
Phnom Penh 7
Reykjavik 7
San Francisco 7
Sanaa 7
Sofia 7
Turin 7
Warsaw 7
Willemstad 7
Belo Horizonte 6
Bishkek 6
Cape Town 6
Cayenne 6
Totale 5.610
Nome #
“Modello di indicatori di qualità” dell’IFCC WG-LEPS: Risultati ed evoluzione del progetto. 489
Indicatori di Qualità nei Point Of Care Testing (POCT): Sono efficaci? 470
Quality indicators to detect pre-analytical errors in laboratory testing 171
Harmonization of pre-analytical quality indicators. 158
An Italian External Quality Assessment (EQA) program on urinary sediment. 157
What information on measurement uncertainty should be communicated to clinicians, and how? 149
Performance criteria and quality indicators for the pre-analytical phase. 148
Assessment of package inserts for diagnostic kits. 148
An integrated system for monitoring the quality of sample transportation. 146
External Quality Assessment: an effective tool for Clinical Governance in Laboratory Medicine 145
A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: Preliminary findings in China 141
Decision Support and Patient Safety 140
Reply to W.G. Wood. Questionable results - who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073 136
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 136
Reference intervals: Are interlaboratory differences appropriate? 135
High-performance liquid chromatography for cyclosporin measurement: comparison with radioimmunoassay 135
Quality indicators for laboratory diagnostics: consensus is needed. 131
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 130
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 130
Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness 129
Extra-analytical sources of uncertainty: which ones really matter? 127
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics 127
A rapid, specific enzyme immunoassay for follitropin and lutropin determination. 125
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 125
External quality assessment for biochemical markers of myocardial damage: an Italian experience. 124
Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. 123
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study 123
Assessment and monitoring of agreement among professionals for morphological evaluation in compliance with International accreditation standard requirements 119
Risk management in laboratory medicine: quality assurance programs and professional competence. 116
The silk road to total quality in Laboratory Medicine 116
Appropriateness of cholesterol and triglycerides reporting checked by External Quality Assessment programs 114
External Quality Assessment Schemes: need for recognised requirements 111
Preanalytical challenges - time for solutions 110
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers 110
Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: A consensus statement on behalf of the IFCC Working Group "laboratory Error and Patient Safety" and EFLM Task and Finish Group "performance specifications for the extra-analytical phases" 109
Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation 109
The use of extra-analytical phase quality indicators by clinical laboratories: The results of an international survey 107
Once upon a time: A tale of ISO 15189 accreditation 107
Effects of sample transportation on commonly requested laboratory tests. 105
La consulenza del Laboratorio nella gestione del Point Of Care Testing (POCT). 105
External quality assessment programs in the context of ISO 15189 accreditation 104
QUALITY INDICATORS IN LABORATORY MEDICINE: THE EXPERIENCE OF A LARGE LABORATORY 103
Extra-analytical quality indicators and laboratory performances 100
Evaluation of an ELISA for SARS-CoV-2 antibody testing: Clinical performances and correlation with plaque reduction neutralization titer 100
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 99
Quality specifications in EQA schemes: from theory to practice 98
Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? 98
Measurement uncertainty: Light in the shadows 98
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy 95
Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes. 94
Performance specifications of critical results management 93
Harmonization of units and reference intervals of plasma proteins: State of the art from an External Quality Assessment Scheme 92
Protocollo operativo per la verifica della comparabilità dei risultati di laboratorio ottenuti su più procedure analitiche 90
Different approaches for estimating measurement uncertainty: An effective tool for improving interpretation of results 89
Post-standardization of routine creatinine assays: are they suitable for clinical applications 88
APPROPRIATENESS OF CLINICAL REQUEST: IS IT POSSIBLE TO MEASURE IT? 87
Critical laboratory results: communication is just one of the problems. 83
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy Expert opinion document from the Study Group of Cardiac Biomarkers associated to the Italian Societies ELAS (European Ligand Assay Society, Italy Section), SIBIoC (Società Italiana di Biochimica Clinica), and SIPMeL (Società Italiana di Patologia Clinica e Medicina di Laboratorio) 83
Laboratory-related errors: you cannot manage what you don't measure. You manage what you know and measure 82
POINT OF CARE TESTING (POCTS): THE IMPORTANCE OF CRITICAL PROBLEMS REPORTING 82
Serum bone alkaline phosphatase in the follow-up of skeletal metastases. 81
IFCC project “Model of quality indicators”: a method for results evaluation 79
Innovative software for recording preanalytical errors in accord with the IFCC quality indicators 77
Serological diagnostic for SARS-CoV-2: An experimental External Quality Assessment Scheme 77
The standardization of plasma protein checked by an external quality assessment scheme (EQAS) 75
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice 75
Quality Indicators for the Total Testing Process 74
Quality indicators to detect pre-analytical errors: a lighthouse in the night. 71
Extra-analytical quality indicators - Where to now? 69
Garantire la comparabilità dei risultati nel rispetto dei requisiti di qualità e delle esigenze organizzative: l’esempio di una procedura operativa 68
Importance of control materials in quality assessment of cyclosporine determination. 65
Commutability of external quality assessment materials for point-of-care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches 62
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy 56
Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project 48
Totale 8.671
Categoria #
all - tutte 28.924
article - articoli 26.053
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021760 0 0 30 83 33 80 39 72 133 52 82 156
2021/20221.067 57 101 158 67 23 85 59 109 45 40 110 213
2022/2023693 149 49 31 47 115 66 17 60 80 24 38 17
2023/2024474 26 41 45 45 37 30 63 22 27 17 55 66
2024/20251.639 16 106 70 79 213 34 118 113 135 68 288 399
2025/20261.642 227 564 851 0 0 0 0 0 0 0 0 0
Totale 8.671